Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-11 4:00 pm Purchase | 2026-03-09 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 11,969,079 12.900% | 34,400 (+0.29%) | Filing History |
| 2026-03-10 5:00 pm Purchase | 2026-03-06 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 8,604,852 8.800% | 2,425,810 (+39.26%) | Filing History |
| 2026-03-10 4:38 pm Purchase | 2026-03-06 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 9,663,926 9.900% | 1,666,416 (+20.84%) | Filing History |
| 2026-02-17 4:08 pm Purchase | 2025-12-31 | 13G | Solid Biosciences Inc. SLDB | Vestal Point Capital, LP | 5,815,000 7.500% | 4,061,442 (+231.61%) | Filing History |
| 2026-02-12 09:09 am Sale | 2025-12-31 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management, L.P. | 1,400,000 1.800% | -2,600,000 (-65.00%) | Filing History |
| 2025-11-13 09:07 am Sale | 2025-09-30 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management, L.P. | 4,000,000 5.140% | -2,729,484 (-40.56%) | Filing History |
| 2025-08-14 6:06 pm Purchase | 2025-08-12 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 7,997,510 9.900% | 7,997,510 (New Position) | Filing History |
| 2025-08-14 5:07 pm Sale | 2025-06-30 | 13G | Solid Biosciences Inc. SLDB | Commodore Capital LP | 0 0.000% | -5,825,000 (Position Closed) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | Solid Biosciences Inc. SLDB | BlackRock Inc. BLK | 4,712,573 6.100% | 4,712,573 (New Position) | Filing History |
| 2025-05-15 4:12 pm Sale | 2025-03-31 | 13G | Solid Biosciences Inc. SLDB | Vestal Point Capital, LP | 1,753,558 2.300% | -1,046,442 (-37.37%) | Filing History |
| 2025-05-12 09:04 am Purchase | 2025-03-31 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management, L.P. | 6,729,484 8.680% | 4,975,325 (+283.63%) | Filing History |
| 2025-04-17 6:50 pm Purchase | 2025-03-31 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 7,415,905 9.600% | 3,666,864 (+97.81%) | Filing History |
| 2025-02-25 4:05 pm Purchase | 2025-02-18 | 13G | Solid Biosciences Inc. SLDB | Commodore Capital LP | 5,825,000 7.600% | 5,825,000 (New Position) | Filing History |
| 2025-02-21 6:04 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 6,179,042 7.800% | 3,877,087 (+168.43%) | Filing History |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 7,989,820 9.900% | 3,631,342 (+83.32%) | Filing History |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 11,934,679 15.600% | 5,000,001 (+72.10%) | Filing History |
| 2025-02-14 08:30 am Sale | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LP | 0 0.000% | -1,418,440 (Position Closed) | Filing History |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 3,749,041 9.400% | 1,000,000 (+36.38%) | Filing History |
| 2024-11-14 7:59 pm Purchase | 2024-11-14 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% | 6,934,678 (New Position) | Filing History |
| 2024-11-14 12:02 pm Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Vestal Point Capital, LP | 2,800,000 7.300% | 2,800,000 (New Position) | Filing History |